ask="4.83"
ask_size="200"
average_daily_volume="504295"
bid="4.15"
bid_size="100"
book_value="3.74"
change="+0.07"
change_from_200_day_moving_average="2.68"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-6.35"
change_From_52_week_low="0.39"
change_in_percent="+1.54%"
close="4.63"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="4.80"
high_52_weeks="10.98"
last_trade_date="1/13/2017"
last_trade_price="4.63"
last_trade_size="1124"
last_trade_time="4:00pm"
low="4.51"
low_52_weeks="4.24"
market_capitalization="104.41M"
moving_average_200_day="1.95"
moving_average_50_day="4.44"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.57"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+137.52%"
percent_change_from_50_day_moving_average="+4.26%"
percent_change_from_52_week_high="-57.83%"
percent_change_from_52_week_low="+9.28%"
previous_close="4.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="5.06"
stock_exchange="NMS"
symbol="CASC"
volume="87659"
weeks_range_52="4.24 - 10.98"
